ARCHIVES

Carcinogenesis Testing To Stay In NCI, But Control Will Go To New Group Headed By Rall

This article is from The Cancer Letter archive.

Vol. 04 No. 37 | September 15, 1978

Download PDF Visit The Full Archive

Related Articles

Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival

October 25, 2013

Varmus to NCAB: Budgetary “Haircuts” No Longer Sufficient to Cope With Fiscal Pressure

September 16, 2011

City of Hope Selects Michael Friedman As President, CEO

May 16, 2003

Ontak Approved For Lymphoma

October 31, 2008

Sustained-Release Leuprolide Under Study In Phase III Trial.

June 30, 2000

Successful Treatment by Community MDs Reducing Numbers Of Patients In Research, DCT Board Told; “We can Work With them,” Carbone Says

April 27, 1979